@article{229e1d7d13ff433d8fc1c36fee0f39fb,
title = "Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: evaluation of cardiovascular events in a randomized trial",
abstract = "This study aimed to evaluate prognostic risk factors for cardiovascular events during treatment of metastatic prostate cancer patients with high-dose parenteral polyoestradiol phosphate (PEP, Estradurin{\textregistered}) or combined androgen deprivation (CAD) with special emphasis on pretreatment cardiovascular disease.",
author = "Hedlund, {Per Olov} and Robert Johansson and Damber, {Jan Erik} and Inger Hagerman and Peter Henriksson and Peter Iversen and Klarskov, {Ole Peter} and Peter Mogensen and Finn Rasmussen and Eberhard Varenhorst and Peter Iversen",
year = "2011",
doi = "http://dx.doi.org/10.3109/00365599.2011.585820",
language = "English",
volume = "45",
pages = "346--53",
journal = "Scandinavian Journal of Urology",
issn = "2168-1805",
publisher = "Taylor & Francis",
number = "5",
}